The Calculation of Drug Dosage
and
Body Surface Area
of Children

Alastair Lack and Malvena Stuart-Taylor

  back to Homepage
   
 

Summary

The British National Formulary (1) and many reference textbooks recommend that drug dosages for children be calculated according to body surface area (B.S.A.). Though many rules for drug dosage have been developed, based upon age, weight, and surface area, none have been both accurate and simple enough for routine use. These rules are described, and one for clinical use, that:-

Up to 30kg, a child's drug dose may be (Wt x2)% of adult,
Over 30kg, (Wt +30)% of adult

If this percentage of an ‘adult' dose of a drug is used, not only is the B.S.A. curve followed more closely than with the conventional mg/kg regime, but fewer major errors of prescription may be expected

Introduction

The British National Formulary (B.N.F.)(1), Martindale's Pharmacopoeia (2), and many other reference textbooks state that the most reliable methods for calculation of children's drug doses are those based on body surface area (B.S.A.). This principle has been commended for nearly ninety years, but there is still no consistency in the guidance offered, and the same B.N.F. uses a mixture of mg/kg , age and weight ranges in its recommendations.

All dosage rules based upon a single physical dimension only hold good whilst that dimension is associated with normal other dimensions. Thus one could use an age based rule if associated height and weight for that age are were typical; however there is substantial normal variation of height and weight with age (see later) and so weight is more normally used as the dimension for calculations. This however is still relatively unreliable, so if one seeks better prediction of drug levels, a multidimensional rule is needed. Fortunately this is usually rather beyond clinical needs.

The therapeutic ratio (the ratio of toxic to effective doses) for most drugs is more than 50%, so that some approximation may usually be made with safety. It would appear that for routine practice, an 'accuracy' of 10-20% is reasonable; anything more than this complicates the mathematics substantially, and would not be justified because of individual differences in response. This generalisation excludes those drugs which are given according to known individual requirements (e.g. insulin or digoxin), for which a prescribing rule is inappropriate.

A large number of children's drug dosage rules have been described over the years(3-5), almost all using percentages of an adult dose to calculate an appropriate child's dose - the notable exception being the commonly used ‘n' mg kg -1 regime. An advantage of these rules is that modifications to adult doses to allow for sickness in adults are appropriately incorporated into calculations for children. An obvious requirement of these percentage methods is that adult doses of the drug are known, but for the majority of anaesthetists this does not present a problem, and certainly no more difficulty than the different dosages at different ages noted in the B.N.F.

Reports in the literature quote many examples of prescription errors for children of 2-10 times the recommended dosage(6-10). Many believe that the great majority of these errors would have been noticed if easily calculated percentages of a normal adult dose had been used, since the prescriber may readily check his mathematics by inspection of the figures involved.

Dosage rules may be described as those based on age, weight or body surface area.

Age Based Rules

The earliest rules used age as the base, giving the percentage of an adult dose. Augsberger (3) referred to D illing's rule (Age/20) as going back to the 8th. century. Those most commonly used

Age/20, (4xAge)+20, and Age/(Age+12)

are shown in figure 1

Figure 1

Age based rules at ages shown for the calculation of childrens' drug dosages as a percentage of adult dose plotted using weights derived from standard growth tables

These are plotted using weights for ages obtained from standard tables(11,12). The normal variation of weight with age (from 3rd. to 97th. percentile) is very considerable, being least at one year (+25% to -20% at 10 kg), and reaching a maximum at about 13 years (+45% to -26% at 40 kg). The consequence is that these rules are highly unreliable.

If weight is unavailable, then (4 x Age)+20 provides the best fit to the B.S.A. curve for normally sized children

Weight Based Rules

Prof. A.J. Clark of Edinburgh is said to have been the first to propose a weight-proportional regime for drug therapy(13). His first rule is

[Wt(lb)/150] fraction of an adult dose

This was improved in accuracy by Augsberger(3), who substituted multiplication for division and added 10, suggesting

[(1.5 x Wt(kg))+10] percent of an adult dose

However, this made it a little difficult to calculate, and this rule is not widely quoted. It is as good a linear fit as can be made to the B.S.A. curve, reaching 100% at 60kg (figure 2).

The most common regime, mg/kg dosages, has an attractive simplicity which has given it widespread popularity despite its disadvantages, namely:-

  • It requires a complete set of drug dosages (n mg/kg ) to be learned for its purpose, and indeed different doses at different ages(1)
  • The mathematics may not be as easy as a bedside rule demands, the decimal point sometimes being misplaced when tenths or hundredths of a mg/kg are being multiplied.
  • It does not immediately relate to adult doses, so that inappropriate prescriptions are not immediately obvious.
  • Assays of drug levels show that its use ‘underdoses' for much of its range(14). This varies from about -45% at 15kg to -20% at 40kg compared with the B.S.A. graph (figure 5).

Figure 2

Weight based rules for the calculation of childrens' drug dosages as a percentage of adult dose; markers at ages

Body Surface Area Calculation

Body Surface Area is recommended as the principal basis for drug dosage(15,16) since the rate of metabolism or redistribution of a drug is proportional to metabolic rate, which in turn reflects heat losses which, as for any warm object, are generally proportional to surface area. Many measurements of organ size, fluid compartment volumes and assays of blood levels of drugs correlate well with B.S.A.(13,17-20).

Whilst this is valid for most ages, some drop below the B.S.A. proportional dose is in fact appropriate when prescribing for children of less than about eighteen months, typically 10kg, since below that age there are differences other than size that should be borne in mind i.e.:-

  • In the neonate, many enzyme systems are immature.
  • Neonatal renal clearance is approximately 50% of adult, reaching adult values at about six months.
  • The half life for many drugs is therefore longer in neonates and infants .
  • Children have higher than adult total body water percentage (80% at birth, 70% at 3 months, and 60% at 1 year, compared with about 55% for adults). This is of importance when considering the distribution volumes of drugs; in children less than one year old, the distribution volume is relatively large for drugs that are water soluble, and small for those that are fat soluble(14, 21-23).

Moore , in 1909(19) was the first to recognise the importance of B.S.A., saying that:-

'stating dosage in reference to body weight is not only inaccurate, but rests entirely on a wrong principle',

that it should be

'proportionately instead to the body surfaces or, in other words, proportionately to the two thirds powers of their weights, which leads to quite different doses.' (1)

Moore is using the same formula as Meeh(24), who is widely quoted. Clark gave his name to his second rule by reporting Moore 's work in 1937(13), again recommending dosage proportional to the two thirds power of the body weight.

The history of actual measurements of surface area is fascinating, with examples of marvellous ingenuity, from covering surfaces with paper, plaster or lead, to ‘wrapping a man in silk tights, charging up the silk as one would a Leyden Jar, and calculating the surface by applying a metal plate of known area' (25). The power of 2/3 is the ratio of surface area to volume of cubes, spheres and other such solid objects, and in humans appears to be a quite reasonable approximation (figure 2) for those of normal build, using a proportionality constant of around 12 for kilograms, i.e. 12 x Wt2/3 (25). It is, however, unidimensional.

The first multidimensional formula for surface area to be widely used was proposed by DuBois and DuBois(26):-

S = W0.425 x H0.725 x 71.84 (2)

where S= Surface Area (sq.cm), W= Weight (Kg), H= Height (cm)

The nomograms derived from this equation are those seen most often, as for example in Martindale's Pharmacopoeia(2) or Geigy Scientific Tables(27), despite the fact that the investigators only measured 9 subjects.

The definitive work on surface area is a monograph by Edith Boyd(28), who improved the formula as follows:-

S = 3.207W 0.7285-0.0188 LogW H0.3 (3)

Where W= Weight (g). She quoted the standard deviation (S.D.) in her subjects as 7%

Gehan and George(29) summarised all existing data, and suggested a further marginal improvement on the above equations, namely

S = 0.0235 H0.42246 W0.51456 (5)

In fact, equations 1 - 5 are within 5% of each other down to 15 kg in persons with a normal build. Thin people would appear to have about 10% more surface area than predicted by Equation 1, and fat people about 20% less(25), but unfortunately the literature does not provide reliable data about variations of B.S.A. with build.

B.S.A. Based Rules

The nomograms constructed from these formulae provide the actual surface area, from which further mathematics will provide the fraction of an adult dose, and thence the required dose, but this is hardly a bedside calculation.

The consensus has generally been that fixed tables of percentages of an adult dose derived from B.S.A.(3,20,30) are a lesser evil than calculations requiring such higher mathematical powers, though they do require interpolation and the consequent possibility of introducing further errors. This approach, first suggested by Butler & Richie(17) and further popularised by Catzel as 'The Percentage Method'(31) again is difficult to use in a clinical situation: the figures may of course be learnt by heart, but this is little more use than nomograms or a calculator. They appear to be the basis of the table given in the B.N.F.(1) (which does not quote its source) and many current textbooks; Catzel's figures (Table 1, Figure 3) follow the B.S.A. curve up to 40kg, from which point they are 5% higher. Differences in the percentages recommended in different sources appear to arise from a combination of approximations and differences in the size of an ‘adult' - whether 140lb., 65kg or 70 kg. Much of this work was done in the early part of the century, since when the normal adult has increased in size.

Catzel's Recommended Doses of Drugs for Children(31)

  Age Weight(kg) % Adult Dose  
 

2/52

3.2

12.5

 
 

2/12

4.5

15

 
 

4/12

6.5

20

 
 

8/12

8.5

25

 
 

12/12

10

28

 
 

18/12

11

30

 
 

3yrs

15

33

 
 

5

18

40

 
 

7

23

50

 
 

10

32

60

 
 

12

40

75

 
 

14

45

80

 
 

20

65

100

 
 
TABLE 1
   
       

Figure 3

Catzel's recommended dose of drugs for children as a percentage of adult dose

SALISBURY RULE

None of the rules described above are both simple and accurate enough for clinical use. A rule is needed that will allow a dosage calculation that is approximately ‘correct', rather than having complicated mathematics in order to achieve academic accuracy, but getting the point wrong.

Since a curve cannot be calculated easily with bedside mathematics; it was decided to use two straight lines crossing over at an appropriate point. As pointed out, the Wt/70 (mg/kg) rule falls substantially below the B.S.A. curve throughout its range, with consequent underdosing.

Wt/50, which is the same as double the body weight as a percentage of the adult dose, makes for easier calculation and provides reasonable results up to 30 kg, though still deviating to the low side at low weights (thereby accommodating the reservations concerning infants described above).

Over 30 kg, one may simply add 30 to the body weight to obtain the graph shown in figure 4, following the B.S.A. curve closely.

Figure 4

The Salisbury rule for drug dosage for children compared with B.S.A. and Wt/70 ( mg/kg )

The difference of the Wt/70 (mg/kg) and Salisbury rules from the B.S.A. curve may be seen in Figure 5

Figure 5

The deviation from the B.S.A. of the Wt/70 ( mg kg) rule and the Salisbury rule

Thus, we propose that children should have:-

 
Less than 30 kg : Weight x 2
 
 
More than 30 kg : Weight + 30
 
    percentage of the adult dose of a drug.
Expressed colloquially, this is:    
 
“To obtain the B.S.A.% from the weight,
 
 
Under 30 double it,
 
 
Over 30, add 30”
 
     

Examples of drug dosage calculations using different rules

Most doses rounded to nearest mg: n/r = not recommended

Weight (kg) 3.2 8.5 18 45  
Atracurium adult dose assumed to be 35mg
  0.5 mg/kg
n/r
3 9 23  
  Salisbury Rule
n/r
6 13 26  
  Catzel/BNF
n/r
9 14 28  
             
Thiopentone ‘Adult' dose assumed to be 280mg
  4 mg/kg 13 34 73 180  
  Salisbury Rule 18 48 101 252  
  Catzel/BNF 35 70 112 224  
             
Morphine ‘Adult' dose assumed to be 10mg. ‘B.N.F.' follows B.N.F. guidance for different age/weight groupings
  0.1- 0.2 mg/kg 0.3-0.6 0.9-1.7 1.8-3.6 4.5-9  
  BNF mg/kg 0.5 1.7 ~4 10  
  Salisbury Rule 0.6 1.7 3.6 9  
  Catzel/BNF 1.25 2.5 5 8  
           
 
Table 2

The results from the Salisbury Rule fall in a safe area close to those recommended by the B.N.F. It is particularly useful that it removes the need to learn different doses at different ages. So, for example, the dose for Morphine is quoted in the B.N.F. as: ‘<1 month, 150 micrograms/kg; 1-12 months 200 micrograms/kg; 1-5 years 2.5-5 mg; 6-12 years 5-10 mg'. The Salisbury Rule tracks these different doses accurately, so eliminating the need for different dosage recommendations at different ages.

The authors have been using this rule now for nearly ten years. It has proved easy to use, and there has been no clinical evidence of inappropriate dosage.

SUMMARY

Nearly ninety years ago the following suggestion was made:-

'For the great majority of drugs the method of stating dosage as so much per kilogram should be abandoned'

Moore ,1909

It has often been repeated, and in order to facilitate this the Salisbury rule is that

Children should have, if they are

Less than 30 kg, double the body weight.
More than 30 kg, add 30 to the body weight.

percentage of the adult dose of a drug.

This rule gives as close adherence to fractional body surface area as is desirable, underdosing where immature development may be present, together with the added advantage of easier and more reliable calculation of the result.

 

  References
   
 

1. British National Formulary. 30th Edn. London: British Medical Association, 1995; 11

2. Reynolds JF, ed. Martindale: The Extra Pharmacopoeia. 29th Edn. London: The Pharmaceutical Press, 1989;

3. Augsberger A. Old and new rules for dosage determination in paediatrics. Triangle (Sandoz) 1962; 5 : 200-207.

4. Allnutt AG. Dosage in relation to dispensing medicine for children. In: Symposium: The Dosage of Medicines. London: Pharmaceutical Society of Great Britain, 1966; 57-66.

5. Ritchell WA. Drug dosage in children. In: Ritchell WA, ed. Handbook of basic Pharmacokinetics. Hamilton, Ill. Drug Intelligence Publications, 1976; 254-266.

6. Briars GL, Bailey BJR. Surface area estimation: pocket calculator v nomogram. Archives of Disease in Childhood 1994; 70 : 246-247.

7. Koren G, Barzilay Z, Modan M. Errors in computing drug dosages. Canadian Medical Association Journal 1983; 129 : 721-723.

8. Wilson ME, Macleod KR. Forum: A nomogram to reduce errors in paediatric drug dose calculation. Anaesthesia 1982; 37 : 951-953.

9. Perlstein PH, Callison C, White M, Barnes B, Edwards NK. Errors in Drug Computations During Newborn Intensive Care. American Journal of Diseases of Children 1979; 133 : 376-379.

10. Shane R, Quon LM. Prevention of medication errors in pediatrics. American Journal of Diseases of Children 1981; 135 : 384

11. Tanner JM, Whitehouse RH, Takaishi M. Standards from Birth to Maturity for Height, Weight, Height Velocity, and Weight Velocity: British Children, 1965 Part 1. Archives of Disease in Childhood 1966; 41 : 454-471.

12. Tanner JM, Whitehouse RH, Takaishi M. Standards from Birth to Maturity for Height, Weight, Height Velocity, and Weight Velocity: British Children, 1965 Part 2. Archives of Disease in Childhood 1966; 41 : 613-635.

13. Clark AJ. Heubner W and Schuller J, eds. Handbuch der experimentellen pharmakologie. 4th Edn. Berlin: Julius Springer, 1937;

14. Kauffman RE, Habersang RWO. Modification of dosage regimens in disease states in childhood. In: Mirkin BL, ed. Disease states of childhood, Symposium on clinical pharmacology and therapeutics: A pediatric prospective. Chicago: Year Book Publishers, 1978; 6, 73-88.

15. Pinkel D. Body Surface and Dosage; a Pragmatic View. Quarterly Review of Pediatrics 1959; 14 : 187-189.

16. Shirkey HC. Dosage (Posology). In: Shirkey HC, ed. Pediatric Therapy. St. Louis: Mosby, 1975; 6, 19-33.

17. Butler AM, Richie RH. Simplification and improvement in estimating drug dosage and fluid and dietary allowances for patients of varying sizes. New England Journal of Medicine 1960; 262 : 903-908.

18. Crawford JD, Terry ME, Rourke GM. Simplification of drug dosage calculation by application of the surface area principle. Pediatrics 1950; 5 : 783-789.

19. Moore B. The relationship of dosage of a drug to the size of an animal treated, especially in regard to the cause of the failures to cure Trypanosomiasis, and other protozoan diseases in man and in other large animals. Biochemical Journal 1909; 4 : 322-330.

20. Shirkey HC. Drug dosage for infants and children. Journal of the Americal Medical Association 1965; 193 : 443-446.

21. Habersang RWO. Dosage. In: Shirkey HC, ed. Pediatric Therapy. 6th Edn. St. Louis: Mosby, 1980; 3, 17-20.

22. Habersang RWO, Kauffman RE. Drug Doses for Children: A rational approach to an old problem. Journal of the Kansas Medical Society 1974; 73 : 98-103.

23. Rylance G. Prescribing in infancy and childhood. British Journal of Hospital Medicine 1979; 22 : 346-354.

24. Meeh K. Oberflachenmessungen des menschlischen Korpers. Zeitschrift fur Biologie 1879; 15 : 425-458.

25. DuBois D, Dubois EF. Clinical Calorimetry: Fifth Paper: The measurement of the surface area of man. Archives of Internal Medicine 1915; 15 : 868-881.

26. DuBois D, Dubois EF. Clinical Calorimetry: Tenth paper: A formula to estimate the approximate surface area if height and weight be known. Archives of Internal Medicine 1916; 17 : 863-871.

27. Diem K and Lentner C, eds. Documenta Geigy Scientific Tables. 7th Edn. Basle: Geigy, 1970; 537

28. Boyd E. The Growth of the Surface Area of the Human Body. Minneapolis: University of Minnesota Press, 1935;

29. Gehan EA, George SL. Estimation of body surface area from height and weight. Cancer Chemotherapy Reports Part 1 1970; 54 : 225-235.

30. Leach RH, Wood BSB. Drug dosage for children. Lancet 1967; 2 : 1350-1351.

31. Catzel P, Olver R. Paediatric Prescriber. 5th Edn. Oxford: Blackwell, 1981; 8-12.

   
 
Return to home